Search Results

Alamar Biosciences (Alamar), and Mologic, Ltd. (Mologic), today announced a collaboration to utilize Alamar’s novel antibodies against SARS-CoV-2 Nucleocapsid (N) protein for Mologic’s future COVID-19 RDTs.

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the latest phase of the Company’s expansion plans.

Collaboration facilitated by the Bill & Melinda Gates Foundation through an expansion of an existing grant to Mologic

Partnership to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing in low and middle income countries

Mologic Ltd announced that it has finished recruitment to a major clinical trial with University College London Hospitals (UCLH) to evaluate the Company’s point-of-care (POC) diagnostic test for the early detection of sepsis.

Mologic Ltd announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®.

Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company’s urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis (CF) patients.

Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it has completed the development of a next generation ultra-sensitive lateral flow-based technology platform. Initially being exemplified through the development of low cost, high performance devices for malaria and HIV, the novel diagnostics can be visually read and demonstrate up to a 1,000-fold improvement in sensitivity over current technology.

Grant awarded by the Wellcome Trust and DFID, as part of UK government’s £46 million international COVID-19 prevention and research package

Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres